We own our lab and the entire production process, allowing us to dictate exact synthesis standards and ensure absolute quality control from start to finish
US patent 6,211.151, EP 0672688, Sikiric at al, Peptides with organo-protective activity
Tesamorelin vs
reduction in fine lines
Choosing Between 0.5 mL and 1 mL Syringes by Peptide | Peptide | Typical Dose | Reconstitution (per vial) | Concentration | Draw Volume | Recommended Syringe | |---|---|---|---|---|---| | BPC-157 | 250 to 500 mcg | 5 mg / 2 mL BAC | 2 to 500 mcg/mL | 10, 20 units | 0.5 mL or 1 mL, 31G | | TB-500 | 2,000, 2 to 500 mcg | 10 mg / 2 mL BAC | 5 to 000 mcg/mL | 40, 50 units | 1 mL, 29G | | GHK-Cu | 1,000, 2 to 000 mcg | 50 mg / 5 mL BAC | 10 to 000 mcg/mL | 10, 20 units | 0.5 mL or 1 mL, 31G | | Ipamorelin | 200 to 300 mcg | 5 mg / 2 mL BAC | 2 to 500 mcg/mL | 8, 12 units | 0.5 mL, 31G | | CJC-1295 (no DAC) | 100 to 200 mcg | 2 mg / 1 mL BAC | 2 to 000 mcg/mL | 5, 10 units | 0.5 mL, 31G | The 0.5 mL syringe improves accuracy for any draw below 20 units because each graduation mark represents 1 unit across a shorter, fatter barrel